June 18, 2020
Eli Lilly Japan said on June 17 that it has launched its ultra-fast acting insulin analogue Lyumjev (insulin lispro) for the treatment of insulin-indicated diabetes. The drug is expected to generate peak sales of 2.8 billion yen in the seventh...read more